VP Investor Relations
Benjamin (Ben) Matone brings to Vaxxinity over 15 years of experience in investor relations and equity capital markets. Prior to joining Vaxxinity, Ben was Senior Director of Investor Relations at Inovio Pharmaceuticals (NASDAQ: INO) where headed its investor relations division for over four and half years, having multiple roles of increasing responsibilities, broadening the company’s equity research coverage and increasing its institutional ownership. Prior to Inovio, Ben managed a successful advisory services consultancy based in Manhattan, exclusive to life science companies, providing investor relations expertise and assisting companies with strategic positioning and fundraising rounds from private financings to IPOs. Ben began his career with NASDAQ working within the capital markets advisory services division for nine years where he held multiple leadership positions, including Director of the Biotechnology Corporate Solutions team. He received his B.Sc. in Finance from the University of Rhode Island-College of Business and has completed graduate work towards his M.S. in Finance from The Pennsylvania State University.